Lean body mass remained mostly stable, so muscle loss was minimal and fat loss was maximized
Currently, GLP-1 agonists are only approved for treating diabetes and obesity
95% CI: 0.0170.046
Ozempic (semaglutide) administration (semaglutide) administration Thinnest needle (32G, 4 mm) on a once-weekly GLP-1 RA included with each pen 1 1 Red Label Pen that delivers doses of 0.25 mg and 0.5 mg Contains 2 mg of Ozempic Delivers only the starting dose of 0.25 mg and a maintenance dose of 0.5 mg Blue Label Pen that delivers doses of 1 mg Contains 4 mg of Ozempic Delivers only the maintenance dose of 1 mg Yellow Label Pen that delivers doses of 2 mg Contains 8 mg of Ozempic Delivers only the maximum maintenance dose of 2 mg Steps to deliver your dose 1 1 No matter if a patient is initiating, maintaining, or escalating their Ozempic pen dose, inform them to follow these steps for proper administration
We're talking like five to 15% of a person's body weight in a year, and we think these GLP-1 like drugs work in part by traveling to the brain and triggering these molecular switches in parts of the brain that control appetite and hunger, they make people's brains feel full and they eat less
In some cases, over-the-counter laxatives may be suggested for short-term relief, but it is crucial for patients to discuss these options with their healthcare team to ensure they are safe and appropriate for their specific situation
